Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-07 20:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Start: 2022-05-01. Completion: 2022-10-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
PB119 (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Jia Miao Chengdu, Sichuan, China Site recruitment: Not reported
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2021-01-04. Completion: 2022-03-29 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Metformin (drug)
Exenatide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Shengjing Hospital of China Medical University Shenyang, Liaoning, China Site recruitment: Not reported
Start: 2014-09. Completion: 2022-02 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Basal insulin and exenatide (drug) — also listed as: Basal insulin glargine, Exenatide
Basal insulin only (drug) — also listed as: Basal insulin glargine
Basal insulin and bolus insulin (drug) — also listed as: Basal insulin glargine, Pre-meal insulin lispro
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Mount Sinai Hospital Toronto, Ontario, Canada Site recruitment: Not reported
Diabetes Mellitus Associated With Genetic Syndrome; Wolfram Syndrome
Sponsor
Hadassah Medical Organization
Countries with listed sites
No country reported
Registry dates and results
Start: 2011-03-01. Completion: 2013-03-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Canada · Estonia · Germany · Israel · Italy · Romania · Slovakia · Spain · United States
Registry dates and results
Start: 2016-07-06. Completion: 2018-11-17 (may be estimated). Results are posted in this registry.
Products and interventions (7)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Insulin glargine/lixisenatide fixed ratio combination (drug) — also listed as: HOE901/AVE0010, Soliqua
liraglutide (drug) — also listed as: Victoza
exenatide (drug) — also listed as: Byetta
exenatide extended-release (drug) — also listed as: Bydureon
albiglutide (drug) — also listed as: Tanzeum
dulaglutide (drug) — also listed as: Trulicity
Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor) (drug)
Where the study takes place — 124 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Investigational Site Number 8400064 Birmingham, Alabama, United States Site recruitment: Not reported
Investigational Site Number 8400073 Fountain Hills, Arizona, United States Site recruitment: Not reported
Investigational Site Number 8400047 Phoenix, Arizona, United States Site recruitment: Not reported
Investigational Site Number 8400103 Bakersfield, California, United States Site recruitment: Not reported
Investigational Site Number 8400137 Fresno, California, United States Site recruitment: Not reported
Investigational Site Number 8400043 Huntington Park, California, United States Site recruitment: Not reported
Investigational Site Number 8400124 Lamont, California, United States Site recruitment: Not reported
Investigational Site Number 8400027 Lancaster, California, United States Site recruitment: Not reported
Investigational Site Number 8400098 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400013 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400042 Mission Hills, California, United States Site recruitment: Not reported
Investigational Site Number 8400006 Northridge, California, United States Site recruitment: Not reported
Investigational Site Number 8400021 Orange, California, United States Site recruitment: Not reported
Investigational Site Number 8400126 Rialto, California, United States Site recruitment: Not reported
Investigational Site Number 8400094 Santa Ana, California, United States Site recruitment: Not reported
Start: 2019-05-02. Completion: 2021-07-01 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Sham injection (other) — also listed as: Placebo
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Boston University Psychiatry Research Center, Clinical Studies Unit Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2009-03. Completion: 2016-04 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide 0.27 ng/kg/min (drug) — also listed as: Byetta
Exenatide 0.41 ng/kg/min (drug) — also listed as: Byetta
Placebo (drug) — also listed as: Normal Saline Solution
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Pennsylvania Philadelphia, Pennsylvania, United States Site recruitment: Not reported
Start: 2014-09. Completion: 2020-07 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Bydureon
Placebo (drug) — also listed as: Control
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
UMass Medical School Worcester, Massachusetts, United States Site recruitment: Not reported
Start: 2015-12. Completion: 2020-08-14 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Weight loss with pharmacotherapy (drug) — also listed as: Exenatide extended release
Weight loss without pharmacotherapy (drug) — also listed as: Placebo
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Minnesota Minneapolis, Minnesota, United States Site recruitment: Not reported
Bulgaria · Hungary · Israel · Kuwait · Mexico · Ukraine · United States
Registry dates and results
Start: 2011-12-02. Completion: 2021-05-05 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide Once Weekly (drug) — also listed as: BYDUREON
Placebo (drug)
Where the study takes place — 35 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Research Site Los Angeles, California, United States Site recruitment: Not reported
Research Site New Haven, Connecticut, United States Site recruitment: Not reported
Research Site Iowa City, Iowa, United States Site recruitment: Not reported
Research Site Kansas City, Kansas, United States Site recruitment: Not reported
Research Site Louisville, Kentucky, United States Site recruitment: Not reported
Research Site Boston, Massachusetts, United States Site recruitment: Not reported
Research Site Jackson, Mississippi, United States Site recruitment: Not reported
Research Site Buffalo, New York, United States Site recruitment: Not reported
Research Site Chapel Hill, North Carolina, United States Site recruitment: Not reported
Research Site Charlotte, North Carolina, United States Site recruitment: Not reported
Research Site Cleveland, Ohio, United States Site recruitment: Not reported
Research Site Oklahoma City, Oklahoma, United States Site recruitment: Not reported
Research Site Rapid City, South Dakota, United States Site recruitment: Not reported
Research Site Nashville, Tennessee, United States Site recruitment: Not reported
Research Site Dallas, Texas, United States Site recruitment: Not reported
Research Site Houston, Texas, United States Site recruitment: Not reported
Research Site Pleven, Bulgaria Site recruitment: Not reported
Research Site Sevlievo, Bulgaria Site recruitment: Not reported
Research Site Baja, Hungary Site recruitment: Not reported
Research Site Budapest, Hungary Site recruitment: Not reported
Research Site Budapest, Hungary Site recruitment: Not reported
Research Site Budapest, Hungary Site recruitment: Not reported
Research Site Szeged, Hungary Site recruitment: Not reported
Research Site Beersheba, Israel Site recruitment: Not reported
Research Site Haifa, Israel Site recruitment: Not reported
Research Site Ramat Gan, Israel Site recruitment: Not reported
Research Site Kuwait City, Kuwait Site recruitment: Not reported
Research Site Aguascalientes, Mexico Site recruitment: Not reported
Research Site Durango, Mexico Site recruitment: Not reported
Research Site Guadalajara, Mexico Site recruitment: Not reported
Research Site Veracruz, Mexico Site recruitment: Not reported
Research Site Chernivts?, Ukraine Site recruitment: Not reported
Research Site Ivano-Frankivsk, Ukraine Site recruitment: Not reported
Research Site Kharkiv Region, Ukraine Site recruitment: Not reported
Research Site Odesa, Ukraine Site recruitment: Not reported
Start: 2017-11-23. Completion: 2021-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide Injection (drug) — also listed as: Byetta
Where the study takes place — 15 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
St Vincent's Hospital Sydney Darlinghurst, New South Wales, Australia Site recruitment: Not reported
Liverpool Hospital Liverpool, New South Wales, Australia Site recruitment: Not reported
Sunshine Coast University Hospital Birtinya, Queensland, Australia Site recruitment: Not reported
Royal Brisbane and Women's Hospital Herston, Queensland, Australia Site recruitment: Not reported
Princess Alexandra Hospital Woolloongabba, Queensland, Australia Site recruitment: Not reported
Launceston General Hospital Launceston, Tasmania, Australia Site recruitment: Not reported
Box Hill Hospital Box Hill, Victoria, Australia Site recruitment: Not reported
St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia Site recruitment: Not reported
Austin Hospital Heidelberg, Victoria, Australia Site recruitment: Not reported
Alfred Hospital Melbourne, Victoria, Australia Site recruitment: Not reported
Royal Melbourne Hospital Parkville, Victoria, Australia Site recruitment: Not reported
St John of God Midland Public & Private Hospital Midland, Western Australia, Australia Site recruitment: Not reported
Fiona Stanley Hospital Murdoch, Western Australia, Australia Site recruitment: Not reported
Helsinki University Hospital Helsinki, Finland Site recruitment: Not reported
CDHB Christchurch Hospital Christchurch, New Zealand Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Consano Clinical Research, LLC Shavano Park, Texas, United States Site recruitment: Not reported
Start: 2016-02. Completion: 2021-10-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: bydureon
placebo (other)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Endocrinology Unit Parma, Italy Site recruitment: Not reported
Center for Cognitive Disorders and Dementia AUSL of Parma and University of Parma Parma, Italy Site recruitment: Not reported
Start: 2010-12. Completion: 2017-01-31 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug) — also listed as: Byetta
Rapid and long acting insulin (drug) — also listed as: Novolog/ Humalog, Lantus/ Levemir
long acting insulin + rapid acting + 1.25 mcg Exenatide (drug) — also listed as: Lantus, Levemir
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Albert Einstein CRC- West Campus The Bronx, New York, United States Site recruitment: Not reported
Start: 2012-03. Completion: 2019-01 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Exenatide (drug)
Placebo (drug)
Dietary counseling (behavioral)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2015-04. Completion: 2021-05 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
68Ga-NODAGA-exendin 4 PET/CT (radiation)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Amsterdam UMC, location VU Medical Center Amsterdam, North Holland, Netherlands Site recruitment: Not reported
BD PosiFlush (saline) (drug) — also listed as: Saline
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Novavì ambulatorierne Copenhagen, Frederiksberg, Denmark Site recruitment: Not reported
Start: 2017-05-24. Completion: 2017-06-29 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Bexagliflozin (drug)
Exenatide Injection (drug) — also listed as: Byetta®
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Clinical Research Site Evansville, Indiana, United States Site recruitment: Not reported
Greece · Mexico · Poland · Puerto Rico · Romania · United States
Registry dates and results
Start: 2014-04. Completion: 2015-10 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
LY2944876 (drug)
Exenatide extended-release (drug)
Placebo (drug)
Metformin (drug)
Where the study takes place — 51 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
John Muir Physician Network Clinical Research Center Concord, California, United States Site recruitment: Not reported
Valley Endocrine, Fresno Fresno, California, United States Site recruitment: Not reported
National Research Institute Los Angeles, California, United States Site recruitment: Not reported
Desert Medical Group Inc Palm Springs, California, United States Site recruitment: Not reported
Artemis Institute for Clinical Research San Diego, California, United States Site recruitment: Not reported
Encompass Clinical Research Spring Valley, California, United States Site recruitment: Not reported
Meridien Research Bradenton, Florida, United States Site recruitment: Not reported
M & O Clinical Research, LLC Fort Lauderdale, Florida, United States Site recruitment: Not reported
Suncoast Research Group, LLC Miami, Florida, United States Site recruitment: Not reported
Suncoast Clinical Research New Port Richey, Florida, United States Site recruitment: Not reported
Compass Research Oviedo, Florida, United States Site recruitment: Not reported
Clinical Research of Central Florida Winter Haven, Florida, United States Site recruitment: Not reported
University of Hawaii Honolulu, Hawaii, United States Site recruitment: Not reported
East West Medical Institute Honolulu, Hawaii, United States Site recruitment: Not reported
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States Site recruitment: Not reported
Iderc, P.L.C. Des Moines, Iowa, United States Site recruitment: Not reported
Cotton O'Neil Diabetes and Endocrinology Center Topeka, Kansas, United States Site recruitment: Not reported
Mercy Medical Research Institute Springfield, Missouri, United States Site recruitment: Not reported
St John's Mercy Medical Center St Louis, Missouri, United States Site recruitment: Not reported
Mercy Health Research Washington, Missouri, United States Site recruitment: Not reported
Southern New Hampshire Diabetes and Endocrinology Nashua, New Hampshire, United States Site recruitment: Not reported
High Point Clinical Trials Center High Point, North Carolina, United States Site recruitment: Not reported
Lillestol Research LLC Fargo, North Dakota, United States Site recruitment: Not reported
The Corvallis Clinic P.C. Corvallis, Oregon, United States Site recruitment: Not reported
Blair Medical Associates, Inc. Altoona, Pennsylvania, United States Site recruitment: Not reported
Texas Diabetes and Endocrinology Austin, Texas, United States Site recruitment: Not reported
Dallas Diabetes Endocrine Center Dallas, Texas, United States Site recruitment: Not reported
San Gabriel Clinical Research Georgetown, Texas, United States Site recruitment: Not reported
Oakwell Clinical Research San Antonio, Texas, United States Site recruitment: Not reported
Southwest Health Associates, P.A. Sugar Land, Texas, United States Site recruitment: Not reported
Wade Family Medicine Bountiful, Utah, United States Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ampelokipoi, Greece Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Athens, Greece Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Thessaloniki, Greece Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chihuahua City, Mexico Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampico, Mexico Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bialystok, Poland Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gdansk, Poland Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gdynia, Poland Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lodz, Poland Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szczecin, Poland Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland Site recruitment: Not reported
Manati Medical Center Manati, Puerto Rico Site recruitment: Not reported
American Telemedicine Center San Juan, Puerto Rico Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cluj-Napoca, Romania Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iași, Romania Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ploieşti, Romania Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Târgu Mureş, Romania Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Timișoara, Romania Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.
Investigational Site Number 8400009 Ventura, California, United States Site recruitment: Not reported
Investigational Site Number 8400071 Denver, Colorado, United States Site recruitment: Not reported
Investigational Site Number 8400036 Denver, Colorado, United States Site recruitment: Not reported
Investigational Site Number 8400114 Jacksonville, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400133 Miami, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400058 Port Charlotte, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400084 Tampa, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400112 West Palm Beach, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400045 Lawrenceville, Georgia, United States Site recruitment: Not reported
Investigational Site Number 8400096 Snellville, Georgia, United States Site recruitment: Not reported
Investigational Site Number 8400023 Springfield, Illinois, United States Site recruitment: Not reported
Investigational Site Number 8400049 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400053 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400085 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400120 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400041 Evansville, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400038 Indianapolis, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400130 Council Bluffs, Iowa, United States Site recruitment: Not reported
Investigational Site Number 8400034 Lexington, Kentucky, United States Site recruitment: Not reported
Investigational Site Number 8400091 Lexington, Kentucky, United States Site recruitment: Not reported
Investigational Site Number 8400078 Marrero, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400032 Metairie, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400088 New Orleans, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400033 Baltimore, Maryland, United States Site recruitment: Not reported
Investigational Site Number 8400051 Jefferson City, Missouri, United States Site recruitment: Not reported
Investigational Site Number 8400083 Papillion, Nebraska, United States Site recruitment: Not reported
Investigational Site Number 8400044 Henderson, Nevada, United States Site recruitment: Not reported
Investigational Site Number 8400079 Albany, New York, United States Site recruitment: Not reported
Investigational Site Number 8400061 New York, New York, United States Site recruitment: Not reported
Investigational Site Number 8400123 North Massapequa, New York, United States Site recruitment: Not reported
Investigational Site Number 8400095 Staten Island, New York, United States Site recruitment: Not reported
Investigational Site Number 8400067 West Seneca, New York, United States Site recruitment: Not reported
Investigational Site Number 8400111 Yonkers, New York, United States Site recruitment: Not reported
Investigational Site Number 8400020 Morehead City, North Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400065 Wilmington, North Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400018 Fargo, North Dakota, United States Site recruitment: Not reported
Investigational Site Number 8400019 Columbus, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400056 Dayton, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400125 Mentor, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400099 Oklahoma City, Oklahoma, United States Site recruitment: Not reported
Investigational Site Number 8400129 Scottdale, Pennsylvania, United States Site recruitment: Not reported
Investigational Site Number 8400076 Smithfield, Pennsylvania, United States Site recruitment: Not reported
Investigational Site Number 8400104 Warwick, Rhode Island, United States Site recruitment: Not reported
Investigational Site Number 8400090 Columbia, South Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400139 Austin, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400001 Dallas, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400118 Edinburg, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400008 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400109 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400063 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400106 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400014 North Richland Hills, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400089 San Antonio, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400135 Schertz, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400075 Shavano Park, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400107 Sugar Land, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400054 Orem, Utah, United States Site recruitment: Not reported
Investigational Site Number 8400025 Salt Lake City, Utah, United States Site recruitment: Not reported
Investigational Site Number 8400092 Weber City, Virginia, United States Site recruitment: Not reported
Investigational Site Number 1240003 Burlington, Canada Site recruitment: Not reported
Investigational Site Number 1240006 Corunna, Canada Site recruitment: Not reported
Investigational Site Number 1240002 Red Deer, Canada Site recruitment: Not reported
Investigational Site Number 1240001 Vancouver, Canada Site recruitment: Not reported
Investigational Site Number 2330002 Pärnu, Estonia Site recruitment: Not reported
Investigational Site Number 2330003 Tallinn, Estonia Site recruitment: Not reported
Investigational Site Number 2330001 Tallinn, Estonia Site recruitment: Not reported
Investigational Site Number 2330004 Viljandi, Estonia Site recruitment: Not reported
Investigational Site Number 2760001 Dresden, Germany Site recruitment: Not reported
Investigational Site Number 2760003 Oldenburg in Holstein, Germany Site recruitment: Not reported
Investigational Site Number 3760001 Haifa, Israel Site recruitment: Not reported
Investigational Site Number 3760002 Haifa, Israel Site recruitment: Not reported
Investigational Site Number 3760005 Jerusalem, Israel Site recruitment: Not reported
Investigational Site Number 3760006 Jerusalem, Israel Site recruitment: Not reported
Investigational Site Number 3760004 Tel Aviv, Israel Site recruitment: Not reported
Investigational Site Number 3800008 Bergamo, Italy Site recruitment: Not reported
Investigational Site Number 3800002 Bologna, Italy Site recruitment: Not reported
Investigational Site Number 3800001 Milan, Italy Site recruitment: Not reported
Investigational Site Number 3800006 Milan, Italy Site recruitment: Not reported
Investigational Site Number 3800005 Naples, Italy Site recruitment: Not reported
Investigational Site Number 3800004 Roma, Italy Site recruitment: Not reported
Investigational Site Number 3800003 Roma, Italy Site recruitment: Not reported
Investigational Site Number 6420004 Bacau, Romania Site recruitment: Not reported
Investigational Site Number 6420006 Brasov, Romania Site recruitment: Not reported
Investigational Site Number 6420001 Bucharest, Romania Site recruitment: Not reported
Investigational Site Number 6420008 Buzău, Romania Site recruitment: Not reported
Investigational Site Number 6420003 Cluj-Napoca, Romania Site recruitment: Not reported
Investigational Site Number 6420002 Oradea, Romania Site recruitment: Not reported
Investigational Site Number 6420009 Targoviste, Romania Site recruitment: Not reported
Investigational Site Number 6420007 Târgu Mureş, Romania Site recruitment: Not reported
Investigational Site Number 6420005 Timișoara, Romania Site recruitment: Not reported
Investigational Site Number 7030006 Bratislava, Slovakia Site recruitment: Not reported
Investigational Site Number 7030002 Lučenec, Slovakia Site recruitment: Not reported
Investigational Site Number 7030009 Ľubochňa, Slovakia Site recruitment: Not reported
Investigational Site Number 7030005 Malacky, Slovakia Site recruitment: Not reported
Investigational Site Number 7030007 Prešov, Slovakia Site recruitment: Not reported
Investigational Site Number 7030001 Rožňava, Slovakia Site recruitment: Not reported
Investigational Site Number 7030008 Sabinov, Slovakia Site recruitment: Not reported
Investigational Site Number 7030004 Trenčín, Slovakia Site recruitment: Not reported
Investigational Site Number 7030003 Žilina, Slovakia Site recruitment: Not reported
Investigational Site Number 7240012 Alzira, Spain Site recruitment: Not reported
Investigational Site Number 7240005 Barcelona, Spain Site recruitment: Not reported
Investigational Site Number 7240002 Ferrol, Spain Site recruitment: Not reported
Investigational Site Number 7240008 Málaga, Spain Site recruitment: Not reported
Investigational Site Number 7240011 Pozuelo de Alarcón, Spain Site recruitment: Not reported
Investigational Site Number 7240003 Quart de Poblet, Spain Site recruitment: Not reported
Investigational Site Number 7240006 Sabadell, Spain Site recruitment: Not reported
Investigational Site Number 7240007 Seville, Spain Site recruitment: Not reported
Investigational Site Number 7240009 Seville, Spain Site recruitment: Not reported
Investigational Site Number 7240004 Seville, Spain Site recruitment: Not reported
